DIAXONHIT
Biotechnology Research • 
Paris, Île-de-France, France • 21-50 Employees
Company overview
| Headquarters | 63-65 boulevard Massena, Paris, 75013, FR |
| Phone number | +33389318023 |
| Websites | |
| NAICS | 541714 |
| Keywords | Cancer, Quality Control, Infectious Diseases, Transplantation, Specialty Diagnostic Tests |
| Founded | 1997 |
| Employees | 21-50 |
Key Contacts at DIAXONHIT
Diego Pallares
Director Bioinformatics
Sherry Smith
Director
Heather Jordan
Director Of Operations
Bob Smith
Director
DIAXONHIT Email Formats
DIAXONHIT uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 45.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 45.6% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 22.3% |
{first name}@company.com | john@company.com | 15.1% |
{first name}{last name}@company.com | johndoe@company.com | 9.8% |
{first name}_{last name}@company.com | john_doe@company.com | 7.2% |
About DIAXONHIT
Diaxonhit (NYSE Alternext, FR0004054427, ALEHT) is a French fully integrated leader in in vitro diagnostics, involved from research to commercialization of specialty diagnostic products in the fields of transplantation, infectious diseases and cancer. With many partnerships and a strong presence in hospitals, Diaxonhit has an extensive commercialization network. Through its affiliate, InGen, it commercializes and services, mostly under exclusivity agreements, in-vitro diagnostic kits and advanced equipment, quality control products and rapid tests, including Tetanus Quick Stick ®, a proprietary product. InGen is the leading supplier in France of HLA tests manufactured by Thermo-Fisher/One Lambda,of which it is the largest commercial partner worldwide. The group also owns a diversified portfolio of products in development, including both innovative molecular and non-molecular diagnostics, covering its three main specialty areas: transplantation, immuno-infection and cancer. Diaxonhit headquarters are located in Paris and its affiliate in the Paris region. The Group is listed on NYSE Alternext in Paris and is part of both the NYSE Alternext OSEO Innovation and the Next Biotech indices. Symbol : ALEHT - ISIN Code: FR0004054427 - Reuters : ALEHT.PA - Bloomberg : ALEHT:FP
DIAXONHIT revenue & valuation
| Annual revenue | $3,000,000 |
| Revenue per employee | $125,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $9,600,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
DIAXONHIT has 11 employees across 7 departments.
Departments
Number of employees
Funding Data
DIAXONHIT has never raised funding before.
DIAXONHIT Tech Stack
Discover the technologies and tools that power DIAXONHIT's digital infrastructure, from frameworks to analytics platforms.
CDN
CDN
JavaScript libraries
Tag managers
Miscellaneous
Security
Miscellaneous
Page builders
Widgets
Hosting
Analytics
Maps
Canada
United Kingdom
New Zealand
CzechiaFrequently asked questions
4.8
40,000 users
